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Abstract
Background: Adult mammalian cardiac myocytes are generally assumed to be terminally differentiated; nonetheless, a small
fraction of cardiac myocytes have been shown to replicate during ventricular remodeling. However, the expression of
Replication Factor C (RFC; RFC140/40/38/37/36) and DNA polymerase d (Pol d) proteins, which are required for DNA
synthesis and cell proliferation, in the adult normal and hypertrophied hearts has been rarely studied.
Methods: We performed qRT-PCR and Western blot analysis to determine the levels of RFC and Pol d message and proteins
in the adult normal cardiac myocytes and cardiac fibroblasts, as well as in adult normal and pulmonary arterial hypertension
induced right ventricular hypertrophied hearts. Immunohistochemical analyses were performed to determine the
localization of the re-expressed DNA replication and cell cycle proteins in adult normal (control) and hypertrophied right
ventricle. We determined right ventricular cardiac myocyte polyploidy and chromosomal missegregation/aneuploidy using
Fluorescent in situ hybridization (FISH) for rat chromosome 12.
Results: RFC40-mRNA and protein was undetectable, whereas Pol d message was detectable in the cardiac myocytes
isolated from control adult hearts. Although RFC40 and Pol d message and protein significantly increased in hypertrophied
hearts as compared to the control hearts; however, this increase was marginal as compared to the fetal hearts.
Immunohistochemical analyses revealed that in addition to RFC40, proliferative and mitotic markers such as cyclin A,
phospho-Aurora A/B/C kinase and phospho-histone 3 were also re-expressed/up-regulated simultaneously in the cardiac
myocytes. Interestingly, FISH analyses demonstrated cardiac myocytes polyploidy and chromosomal missegregation/
aneuploidy in these hearts. Knock-down of endogenous RFC40 caused chromosomal missegregation/aneuploidy and
decrease in the rat neonatal cardiac myocyte numbers.
Conclusion: Our novel findings suggest that transcription of RFC40 is suppressed in the normal adult cardiac myocytes and
its insufficient re-expression may be responsible for causing chromosomal missegregation/aneuploidy and in cardiac
myocytes during right ventricular hypertrophy.
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Introduction
Adult mammalian heart is a terminally differentiated organ. It is
made of two major cellular components, cardiac myocytes (CMs)
and cardiac fibroblasts (CFs), which collectively constitute for
approximately 90% of the cells in the myocardium [1]. CFs
constitute for approximately 60–70% of the non-myocyte cells in
the heart [1]. Although, they are known to retain their replicative
properties in the adult heart, they are normally quiescent and
proliferate into myofibroblasts only during patho-physiological
remodeling of the heart [2]. In contrast, CMs which constitute
about 30% of the human heart [1] cease to proliferate soon after
birth and become post-mitotic or terminally differentiated [3,4].
Therefore, the CMs in adult heart are unable to regenerate
myocardial tissue after injury by ischemia-reperfusion insult and
during heart failure. However, this paradigm has been shifted
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39009slightly in the past few years and there is a growing body of
evidence that CMs from diseased heart can replicate during
ventricular remodeling [5,6]. Previous studies have demonstrated
that transgenic over-expression of either oncogenes or cell cycle
promoters leads to cell cycle activation in adult CMs [7].
Although, adult CMs have been shown to proliferate and
regenerate following induction with growth factors [8,9], none-
theless, clear evidence that normal adult CMs can undergo basal
DNA synthesis is forthcoming [7]. Furthermore, the factor(s)
responsible for preventing DNA replication in adult CMs is not
clearly understood.
DNA replication is one of the challenging steps in the cell cycle
and requires the collaboration of a formidable number of proteins
[10]. In eukaryotes, several accessory proteins such as Replication
Factor C (RFC) and Proliferating Cell Nuclear Antigen (PCNA),
confer speed and high processivity to the replicative polymerases,
DNA polymerases d (Pol d) and e. The RFC functions as a clamp
loader that loads PCNA, the clamp, onto DNA and consists of five
subunits, RFC140, RFC40, RFC38, RFC37 and RFC36. The
assembly of the RFC commits the cell to DNA replication and has
significant influence on cell cycle transition from DNA replication
to cell division [11]. Since CMs exit the cell cycle soon after birth,
it is imperative to know the fate of these major DNA replication
proteins in the adult heart cells. Although, previous studies have
demonstrated down-regulation of DNA replication proteins in the
adult heart [12,13,14], however, whether the expression of RFC
and Pol d proteins are down-regulated in adult normal CMs and
CFs is still elusive. In this study, we show that transcription of
RFC40 gene and translation of the catalytic subunit of Pol d
protein, p125, are suppressed in the normal adult CMs.
Considering the differences in the replicative properties of the
CMs and CFs, post-natal growth of the heart is defined as CMs
hypertrophy and CFs hyperplasia [2], subsequently leading to
cardiac pathologies. Pulmonary arterial hypertension (PAH) is a
fatal syndrome which is characterized by vasoconstriction and
vascular remodeling of the pulmonary artery leading to increase in
pulmonary arterial pressure [15]. Right ventricular (RV) hyper-
trophy occurs to compensate the severe pressure overload in PAH,
thereby increasing the mortality rates in patients with PAH. Unlike
left ventricular (LV) hypertrophy or failure, the molecular cause(s)
in the pathogenesis of RV hypertrophy has rarely been studied
and remains unknown. Besides, it is unclear whether increase in
pulmonary arterial pressure, inhaled hypoxemia or combination of
both triggers right heart growth in pulmonary hypertension
diseases [16]. Several studies have demonstrated up-regulation of
PCNA, in infracted and failing hearts [17] and right ventricular
hypertrophy [18], and cell cycle proteins in acute myocardial
infarction and heart failure [19,20], however the status of RFC
and Pol d proteins in cardiac pathologies has rarely been studied.
This study was undertaken to determine the expression of the RFC
and Pol d proteins in adult normal CMs and CFs and in PAH-
induced RV hypertrophied hearts. In this study, we used an
established Sugen-5416-induced PAH rat model, characterized by
the formation of pulmonary vascular lesions closely resembling the
one found in human PAH, leading to the development of severe
RV hypertrophy and failure [21,22]. We found that RFC40 and
Pol d message and protein significantly increased in hypertrophied
hearts as compared to the control hearts along with re-expression
of RFC40 and up-regulation of mitotic markers in the hypertro-
phied CMs. Fluorescent in situ hybridization studies for rat
chromosome 12, demonstrated cardiac myocyte polyploidy and
chromosomal missegregation/aneuploidy in the hypertrophied
hearts, suggesting that re-expression of DNA replication proteins
were in-sufficient to support cell proliferation. Consistent with this
notion, we also observed chromosomal/aneuploidy missegregation
and decreased cell numbers, following down-regulation of
endogenous RFC40 in the rat neonatal CMs.
Materials and Methods
Details of the following methods can be accessed in the
Materials and Methods S1 file online.
Animals
Pulmonary hypertension and cardiac hypertrophy was pro-
duced in adult male Sprague-Dawley rats (Harlan Laboratories,
IN, USA) weighing 180 to 220 g (n=10) as described previously
[20] with vascular endothelial growth factor (VEGF) receptor
blocker, Sugen-5416 (20 mg/kg) and exposed to hypoxia (10%
O2) for 3 weeks (SUHx-3 wks). Five of these rats were then
returned to normoxia (21% O2) for an additional 2 weeks (after
Sugen-5416 injection +3 wks hypoxia; SUHxNx-5 wks) during
which time they developed severe right ventricular hypertrophy.
An additional 5 rats were used as time-matched normal controls
(Control; without Sugen-5416 injection and hypoxia). Right and
left ventricular systolic pressures were measured as previously
described [22]. Right and left ventricles were separated from
control and hypertrophied hearts for the experiments described in
the present study. We studied two different time-points in the
progression of hypertrophy; hypoxia plus pressure overload and
pressure load alone.
Timed-pregnant female Sprague-Dawley rats were purchased
from Charles River. The timed-pregnant dams were euthanized at
the gestational age of day 15 and fetuses were immediately
removed for isolation of their hearts. A pool of 50 whole hearts
harvested from 15 day-old fetuses was used as a positive control.
All experimental protocols were approved by the Institutional
Animal Care and Use Committee of the University of South
Alabama. The investigation conforms to the Guide for the Care
and Use of Laboratory Animals published by the US National
Institutes of Health. See Materials and Methods S1.
Isolation of Ventricular Myocytes and Fibroblasts
The adult SD rats were deeply anesthetized by injection lethal
dose of Nembutal (150 mg/kg) and single ventricular myocytes
were isolated from rat hearts as described previously [23]. CFs
were separated from the CMs by differential centrifugation and
then used for either western blot analysis or t-RNA extraction. See
Materials and Methods S1.
Immunoblotting
CMs and CFs pellets, fetal hearts, LV and RV isolated from
control, SUHx-3 wks and SUHxNx-5 wks treated heart tissues
were homogenized in lysis buffer and the homogenates (50 mg)
were then analyzed by 12% and 9% SDS-polyacrylamide gels.
Western blot analysis was performed as described previously [10].
See Materials and Methods S1.
Total RNA (t-RNA) Extraction and One-step Real-time RT-
PCR
Total RNA was extracted from freshly isolated adult CMs, fetal,
control and hypertrophic LV and RV tissues using the RNeasy
fibrous tissue mini kit and from freshly isolated adult CFs using the
RNeasy mini kit (Qiagen). Total RNA (50 ng) isolated from each
of these samples (n=5 for each group) was subjected to real-time
one-step-RT-PCR using the iScript One-Step RT-PCR kit
(Biorad). Assays for quantification of RFC40, p125, and GAPDH
mRNA expression were conducted using the iCycler (BioRad).
RFC40 and Chromosomal Missegragation
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visualized on 3% agarose gels. See Materials and Methods S1.
Immunohistochemistry
Control and SuHxNx-5 wks RV slides were incubated with
polyclonal anti-PCNA and anti-RFC40 (both from Abgent), anti-
Cyclin A and anti-phospho-Histone 3 (Ser-10; pHis3; both from
Santa Cruz Biotech) and anti-phospho-Aurora A/B/C kinase
(Cell Signaling tech. Inc.) respectively, and monoclonal anti-
cardiac Troponin-I (Santa Cruz Biotech) overnight at 4uC, and
then with Alexa-568-labeled anti-rabbit and Alex-488-labeled
anti-mouse secondary antibodies for one hour at room temper-
ature. Nucleus was counterstained with DAPI and images were
collected using an Olympus Plan x20/NA 0.25 Phi objective. See
Materials and Methods S1.
Nuclear area was analyzed for .100 CM nuclei from three
individual animals in control and hypertrophied RVs measure-
ments using Image J software.
DNA Probe and Labeling
BAC clone (Children’s Hospital Oakland Research Institute)
representing the centromeric region of rat chromosome 12
(Cen12) was labeled with rhodamine (Cen12-ROX) by Empire
Genomics.
Fluorescent in-situ Hybridization (FISH) Analysis and
Immunohistochemistry
Control and SuHxNx-5 wks RV slides were digested with
Proteinase K (New England Biolabs, Inc.) and FISH was
performed by co-hybridization of the tissues with the Cen12-
ROX probe at 90uC for 10 min followed by overnight hybridiza-
tion at 37uC. Nuclei were counterstained with 0.125 mg/ml of
DAPI antifade (49-6-diamidino-2-phenlindole; Cytocell). Slides
were imaged with Spectral Imaging Software (Applied Spectral
Imaging) using an Olympus BX61 microscope with 1000X
magnification. Fifty CM nuclei were measured from three
individual animals in control and hypertrophied RVs.
Immunohistochemical analysis was performed after imaging the
slides for FISH signals as mentioned above with monoclonal anti-
cardiac Troponin-I (1:50) antibody. Nuclei were counterstained
with DAPI. See Materials and Methods S1.
DNA Replication Assays
M13mp18 DNA (1 pmole; New England Biolabs) was primed
with 20 pmoles of a 80-mer-59-biotinylated-M 13 primer
(Invitrogen) as described previously [24,25,26,27]. DNA synthesis
in a standard reaction mixture (30 ml) containing 100 ng of primed
M13mp18 was started by the addition of 20 mg of total protein
lysates obtained from fetal, control-RV, SUHx-3 wks-RV and
SUHxNx-5 wks-RV tissues, respectively, and the primer extension
products were separated on urea (7 M) - polyacrylamide 6% (v/v)
gel and visualized using the chemiluminescent nucleic acid
detection kit (Pierce). See Materials and Methods S1.
Immunodepletion Assays
Fetal hearts and RVs isolated from control, SUHx-3 wks and
SUHxNx-5 wks hearts were homogenized as described above.
1 mg of total protein lysates from each sample was used for
immunoprecipitation/immunodepletion experiments, using rabbit
polyclonal anti-RFC40 antibody, as described previously [10].
20 mg of total protein lysates obtained from each samples after
immunodepletion were used for the DNA replication assay as
mentioned above. See Materials and Methods S1.
siRNA Studies
Rat Neonatal cardiac myocytes (RNCMs) were isolated as
described previously [28] and grown in 12-well plates (0.5610
6
for western blot and cell number analyses) and 2-chambered
slides (0.125610
6 for FISH) for 48 hr. RNCMs were then
treated with non-targeting-siRNA (NT; 100 nM; Dharmacon)
and On-Target plus smartpool RFC40-siRNA (100 nM; Dhar-
macon) respectively, for 72 hr. Cells lysates were subjected to
Western blot analysis using anti-RFC40 antibody as described
above. GAPDH was used as loading control. Before lysing, the
RNCMs (n=3) were trypsinized, resuspended in 1X PBS and
counted using a hemocytometer. RNCMs grown in 2-cham-
bered slides were subjected to FISH analysis following treatment
with RFC40-siRNA as described previously [29], with few
modifications (See Materials and Methods S1). Control and
RFC40-siRNA-RNCM slides were co-hybridization with the
Cen12-ROX probe (Red). Nuclei were counterstained with
DAPI antifade (Blue). RFC40 knock-down was confirmed by
performing immunohistochemical analyses for RFC40 (Green)
in each sample.
Statistical Analysis
Values are reported as mean6SE. ANOVA and post-hoc Fisher’s
protected t-test or Student’s t-tests were used for analyzing all the
data. Values of P,0.05 were considered significant. In all cases,
the number of experimental determinations (n) was equal to the
number of hearts from which LV & RV were harvested for this
study.
Results
Differential Expression of the DNA Replication Proteins in
CMs and CFs
We isolated CMs and CFs from normal adult heart and
performed Western blot analyses for RFC, PCNA and p125
proteins to determine the cell type in which they are expressed.
Purity of each fraction was first confirmed by cell specific
markers, viz; Troponin I for CMs and S100A4 for CFs
(Figure 1A). RFC40 (Figure 1B and C) protein was not detected
in both CMs and CFs, while RFC140 and RFC38 proteins
(Figure 1B) were expressed in both. Furthermore, PNCA
(Figure 1B), RFC37 (Figure 1B) and p125 (Figure 1B and C)
proteins were expressed only in the CFs. Real time qRT-PCR
demonstrated that p125-mRNA was transcribed in both cell
types (Figure 1D-middle panel), with significant higher expres-
sion in the CFs as compared to the CMs (Figure 1E). Strikingly,
however, RFC40-mRNA was transcribed only in the CFs but
not in the CMs (Figure 1D-top panel and 1 E).
DNA Replication Proteins are Re-expressed in
Hypertrophied Right Ventricle
Previous studies have demonstrated the up-regulation of fetal
genes in most forms of hypertrophy [30]. Up-regulation of
PCNA in the diseased hearts [17] raised the question of
whether RFC37, RFC40 and p125 proteins, that are absent in
the normal CMs, are also re-expressed/up-regulated in hyper-
trophied RV. We therefore used an established rat model of
PAH-induced RV hypertrophy to determine the expression of
all the DNA replication proteins. Adult rats injected subcuta-
neously with Sugen-5416 (SU; 20 mg/kg) and exposed to
hypoxia (10% O2; SUHx) for 3 weeks (SUHx-3 wks; n=5) and
those that were returned to normoxia for an additional 2 weeks
(SUHxNx-5 wks; n=5) developed severe pulmonary hyperten-
RFC40 and Chromosomal Missegragation
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39009sion as reflected by elevated RV systolic pressure (Figure S1 for
the first supporting information figure). We performed Western
blot analyses using the fetal, adult normal and hypertrophied
hearts and found that the expression of p125, RFC37, RFC140
and PCNA were significantly down-regulated in adult control
hearts as compared to fetal hearts (Figure 2A). Although, all
these proteins were up-regulated in the hypertrophied hearts
(Table 1), only p125 was significantly up-regulated both in the
LV and RV of the hypertrophied hearts (Figure 2A, B and C).
Interestingly, RFC40 expression was below detectable levels in
the adult hearts, however, it was significantly re-expressed
(P,0.05) in the hypertrophied RV (Figure 2C) than the LV
(Figure 2B), although not at the fetal levels (Figure 2A).
Up-regulation/Re-expression of Replication Proteins
in Hypertrophied Hearts Occurs at the Transcription
Level
To determine whether the up-regulation/re-expression of the
replication proteins in the hypertrophied myocardium occurred
at the transcriptional level, we quantified mRNA for RFC40
and p125 in fetal, control and hypertrophied hearts by qRT-
PCR and the amplified samples were ran on agarose gel to
determine their molecular size and specificity at the end of each
run (Figure S2 for the second supporting information figure).
Quantitative analysis demonstrated that RFC40-mRNA and
p125–mRNA in adult LV and RV decreased to 5–10% of those
in fetal hearts (which may probably account for that present in
Figure 1. Differential expression of the DNA replication proteins in CMs and CFs. (A) CMs (n=5) and CFs (n=5) were isolated from normal
adult heart and lysates (50 mg) were then analyzed by 12% or 9% SDS-polyacrylamide gels. Purity of the two fractions were confirmed by Western
blot analyses for Troponin I-C (CMs) and S100A4 (CFs) proteins respectively. (B) Expression of RFC37, RFC38, RFC40, RFC140, PCNA and p125 proteins
in the CMs and CFs was determined by Western blot analyses. Whole hearts isolated from 15 day-old fetus (n=5) were used as a positive control (Ft).
GAPDH was used as the loading control. (C) Graphs represent protein expression of RFC40 and p125, normalized by GAPDH in the CMs and
fibroblasts, respectively. (D) Total RNA (50 ng) extracted from CMs and fibroblasts pellets (n=5) was subjected to real-time one-step-RT-PCR. At the
end of each run the amplified products of RFC40, p125 and GAPDH mRNA/cDNA were visualized on 3% agarose gels. Total RNA extracted from whole
hearts of 15 day-old fetus (n=5) were used as a positive control (Ft). (E) Graphs represent the mRNA levels in the CMs and CFs calculated from the
crossing point deviation and normalized by GAPDH values. Values are mean 6 SE. BDL: Below detectable levels.
doi:10.1371/journal.pone.0039009.g001
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3.4-fold (P,0.05) in SUHx-3 wks and SUHxNx-5 wks hearts
(Figure 3A), p125-mRNA increased by 7.6 to 40-fold in SUHx-
3 wks and SUHxNx-5 wks hearts, respectively (Figure 3B) as
compared to the control hearts. Nonetheless, this increase was
marginal as compared to the fetal hearts.
Figure 2. DNA replication proteins are re-expressed in hypertrophied RV. Total protein lysates (50 mg) obtained from LV and RV tissues
(n=5) of the control (Con), SUHx-3 wks (3 wks) and SUHxNx-5 wks (5 wks) were analyzed by 12% or 9% SDS-polyacrylamide gels. (A) Expression
of RFC37, RFC38, RFC40, RFC140, PCNA and p125 proteins was determined by Western blot analyses. Whole hearts isolated from 15 day-old
fetus (n=5) were used as a positive control (Ft). GAPDH was used as the loading control. (B and C) Graphs represent summary data for the
protein expression of RFC40 and p125 proteins in LV (B) and RV (C) normalized by GAPDH (n=5). Values are mean 6 SE. *indicates P,0.05 vs.
control.[/LOOSEST]
doi:10.1371/journal.pone.0039009.g002
Table 1. Expression of DNA replication proteins in control and hypertrophied hearts.
Protein Control SuHx-3 wks SuHx-5 wks
LV RV LV RV LV RV
RFC37 0.015 (0.02) 0.018 (0.03) 0.050
ns (0.09) 0.045
ns (0.07) 0.003
ns (0.003) 0.023
ns (0.04)
RCF38 0.096 (0.04) 0.158 (0.11) 0.060
ns (0.06) 0.050
ns (0.02) 0.080
ns (0.04) 0.090
ns (0.07)
RFC140 0.024 (0.02) 0.017 (0.01) 0.043
ns (0.043) 0.045
* (0.031) 0.069
ns (0.003) 0.031
ns (0.03)
PCNA 0.055 (0.04) 0.028 (0.03) 0.125
ns (0.11) 0.175
ns (0.17) 0.070
ns (0.03) 0.131
* (0.05)
All values are mean 6SD; ns-non-significant;
*P,0.05 vs control.
doi:10.1371/journal.pone.0039009.t001
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Cyclin A, Phospho-Aurora A/B/C Kinase and Phospho-
Histone 3 Positive CMs Nuclei in Hypertrophied RV
To determine whether RFC40 was re-expressed in the
hypertrophied heart CMs we performed immunohistochemical
analyses for RFC40 in the RV isolated from the control and
SUHxNx-5 wks treated hearts (since up-regulation of the replica-
tion proteins were more pronounced in the hypertrophied RVs).
Although we found no staining for RFC40 in the control RV
(Figure 4A; left), positive nuclear RFC40 staining (red/pink) of
CMs was noted in the RV of the SUHxNx-5 wks treated hearts
(Figure 4A; right). PCNA staining of the CMs were performed to
demonstrate the proliferating status of the CMs. While no PCNA
positive nuclei were found in control RV (Figure 4B; left), intense
CMs staining was observed in SUHxNx-5 wks treated RV
Figure 3. Up-regulation/re-expression of replication proteins in hypertrophied hearts occurs at the transcription level. Total RNA
(50 ng) extracted from LV and RV tissues (n=5) of the control (Con), SUHx-3 wks (3 wks) and SUHxNx-5 wks (5 wks) was subjected to real-time one-
step-RT-PCR. The amplified products of RFC40, p125, and GAPDH mRNA/cDNA were visualized on 3% agarose gels at the end of each run. Total RNA
extracted from whole hearts of 15 day-old fetus (n=5) were used as a positive control (Ft). Graphs represent the changes in the mRNA levels for
RFC40-mRNA (A) and p125-mRNA (B) calculated from the crossing point deviation of all the samples and normalized by GAPDH values. Values are
mean 6 SE. *indicates P,0.05 vs. control.
doi:10.1371/journal.pone.0039009.g003
RFC40 and Chromosomal Missegragation
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39009(Figure 4B; right). Furthermore, to determine if the CMs in the
SUHxNx-5 wks treated hearts had re-entered the cell cycle, we
performed immunohistochemical analyses for S-phase and G2/M
phase proteins; Cyclin A, phospho-Aurora A (Thr288)/B
(Thr232)/C (Thr198) kinase and phospho-Histone 3 (H3P; Ser-
10) respectively, and observed no Cyclin A positive nuclei in the
control RV (Figure 4C; left), but intense CMs staining for Cyclin A
was observed in the SUHxNx-5 wks treated RV (Figure 4C; right).
Although, we observed few phospho-Aurora A(Thr288)/
B(Thr232)/C(Thr198) kinase (Figure 4D; left) and H3P
(Figure 4E; left) positive nuclei in the control RV, the intensity
of phospho-Aurora A(Thr288)/B(Thr232)/C(Thr198) kinase and
H3P positive nuclei CMs significantly increased in the SUHxNx-
5 wks treated RV (Figure 4D & E; right). Cardiac Troponin I was
used as a cardiac myocyte marker to distinguish between the CMs
and CFs staining.
Cardiac Myocyte Polyploidy and Chromosomal
Missegregation/aneuploidy was Observed in
Hypertrophied RVs
To determine whether the increased expression of the DNA
replication and S-phase proteins can support DNA synthesis
during the pathogenesis of hypertrophy, we performed Fluorescent
in-situ hybridization (FISH) on control and SUHxNx-5 wks-RVs,
respectively. We used the BAC clone representing the bands
12p11–12q11 of rat chromosome 12 (Cen 12) labeled with 5-
carboxyl-x-rhodamine (5-ROX; Cen12-ROX) as probe for FISH
analyses (Figure S3 for the third supporting information figure).
Interestingly, we noted two different observations in the CM nuclei
of the hypertrophied RV- polyploidy and chromosomal misse-
gregation/aneuploidy. Polyploidy: We observed two signals for
Cen12-ROX (Red) in the CM nuclei from the control RV
(Figure 5A-i). However, two (Figure 5B-i) and four (Figure 5C-i)
signals in the CM nuclei from the hypertrophied RVs was
observed. Localization of the CM nuclei in the control (Figure 5A-
ii) and hypertrophied (Figure 5B–C-ii) RVs were confirmed by
performing immunohistochemical analyses for cardiac Troponin I
(Green). Furthermore, statistical analyses revealed that there was
significant decrease (P,0.05) in the number of diploid CM nuclei
and an increase in the number of polyploid nuclei (Figure 5D) with
concomitant doubling in the nuclear area of the CM nuclei
(Figure 5E) in the hypertrophied RVs as compared to the control
RVs.
To substantiate the previous observations that RFC40 is vital
for DNA replication, we performed in-vitro DNA replication assays
using tissue homogenates obtained from fetal hearts, control-RV,
SUHx-3 wks-RV and SUHxNx-5 wks-RV. Fetal heart lysate
supported robust DNA replication as evident by the primer
Figure 4. Immunohistochemical analyses revealed RFC40, PCNA, Cyclin A, phosphor-Aurora A/B/C kinase and pHis3 positive CMs
nuclei in hypertrophied RV. Control (Con) and SUHxNx-5 wks (5 wks) RV sections (n=3) were incubated with polyclonal anti-RFC40 (A) anti-PCNA
(B), anti-Cyclin A (C), anti-phosho Aurora A/B/C kinase (p-Aurora-A/B/C; D) and anti-H3P (E) antibodies, respectively, and then with Alexa-568-labeled
anti-rabbit and Alex-488-labeled anti-mouse secondary antibodies, respectively. Images were collected using an Olympus Plan x20/NA 0.25 Phi
objective. In each experiment, all data were collected at identical imaging settings. Arrows indicates positive CMs.
doi:10.1371/journal.pone.0039009.g004
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the products obtained with the hypertrophied heart lysates were ,
0.2 kb (Figure 5F-i), suggesting that these hearts partially regained
their DNA replicative capabilities as compared to the control
hearts. However, immunodepletion of RFC40 from the fetal heart
and hypertrophied RV lysates reduced primer extension to less
than 0.3 kb in the fetal heart and almost abolished it in the
hypertrophied hearts (Figure 5F-ii), thus confirming the signifi-
cance of RFC40 in DNA replication.
Chromosomal missegration/aneuploidy. In addition, to
observing two and four signals for Cen12-ROX, we also observed
one (Figure 6B-i), and three (Figure 6C-i) signals in several CM
nuclei from the hypertrophied RVs. Localization of the CM nuclei
in the control (Figure 6A-ii) and hypertrophied (Figure 6B–C-ii)
RVs were confirmed by performing immunohistochemical anal-
yses for cardiac Troponin I (Green). Furthermore, statistical
analyses revealed that there was significant decrease (P,0.05) in
the number of diploid CM nuclei and an increase in the number of
aneuploid nuclei (Figure 6D). Additionally, we also observed some
dividing CMs nuclei exhibiting chromosomal missegregation in
the hypertrophied RVs with one nucleus receiving three sister
chromatids of chromosome 12 while the other receiving only one
sister chromatid (Figure 6E).
Endogenous Knock-down of RFC40 in Rat Neonatal
Cardiac Myocytes Results in Chromosomal
Missegregation/aneuploidy
It has been previously demonstrated that RFC40 is required for
accurate chromosomal segregation in Drosophila [31]. Since we
observed significant aneuploidy and chromosomal missegregation
in the CM nuclei, and since the re-expression of RFC40 in the
hypertrophied RVs was less than 10% of that in the fetal hearts,
we explored the possibility of whether insufficient re-expression of
RFC40 must be responsible for aneuploidy and the chromosomal
segregation defects observed in the hypertrophied hearts. To test
this possibility, we knocked-down endogenous RFC40 protein in
the neonatal (day 2) rat cardiac myocytes (RNCMs) using an On-
Target plus smartpool RFC40-SiRNA for 72 hr. Western blot
Figure 5. Cardiac myocyte polyploidy was observed in hypertrophied RVs. Control (Con) and SuHxNx-5 wks (5 wks) RV sections were used
to perform FISH analyses by co-hybridization of the tissues with the Cen12-ROX probe (Red). Nuclei were counterstained with DAPI antifade (Blue)
and slides were imaged with Spectral Imaging Software using an Olympus BX61 microscope with 1000X magnification. Two FISH signals for Cen12-
ROX was observed in the CM nuclei from the control RV (A-i), whereas two (B-i) and four (C-i) signals were observed in the CM nuclei from the
hypertrophied RVs. Localization of the CM nuclei in the control (A-ii) and hypertrophied (B-C-ii) RVs were confirmed by performing
immunohistochemical analyses for cardiac Troponin I (Green). (D) Graph represents the number of FISH signals for Cen12-ROX observed per CM
nuclei in the control and hypertrophied RVs. Fifty CM nuclei were measured from three individual animals in control and hypertrophied RVs. (E) Graph
represents the nuclear area of .100 CM nuclei measured from three individual animals in control and hypertrophied RVs. Values are mean 6 SE.
*indicates P,0.05 vs. control. (F) In vitro DNA synthesis was carried out using primed M13mp18 ss DNA (100 ng) and protein lysates (20 mg) obtained
from fetal, control-RV (Con), SUHx-3 wks-RV and SUHxNx-5 wks-RV tissues, respectively, before (F-i) and after (F-ii) immunodepletion of RFC40. The
primer extension products were separated on a 7 M urea-6% (v/v) polyacrylamide gel and visualized by the chemiluminescent nucleic acid detection
kit. Lane 1: Biotinylated 2-log DNA ladder (0.5 mg; M) in kilobases (B-lane 1; exposed for only 5 secs to visualize all the bands, is separated by a line).
Lane 2: unannealed biotinylated M13 80-mer primer (BLM13P; 1 fmole). Blot is a representative of three such individual experiments.
doi:10.1371/journal.pone.0039009.g005
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RFC40 protein in the RFC40-siRNA treated samples as compared
to untransfected (UT) and non-targeting-siRNA (NT) treated
RNCMs (Figure S4 for the fourth supporting information figure).
UT and RFC40-siRNA treated RNCMs were subjected to FISH
analyses and RFC40 knock-down was confirmed by performing
immunohistochemical analyses for RFC40 (Green) in each sample
(Figure 7A–D-ii and F–G-ii). As expected, we observed only two
signals for Cen12-ROX (Red) in the UT RNCM nuclei
(Figure 7A-i). Interestingly, we observed one (Figure 7B-i) and
three (Figure 7D-i) signals in the RFC40-siRNA treated RNCM
nuclei. Although, we observed two signals (Figure 7C-i) for few
RNCM nuclei treated with RFC40-siRNA, however, the RFC40
staining for these RNCM nuclei was stronger (Figure 7 C-ii) than
that observed for the RFC40-siRNA treated RNCM nuclei with
one (Figure 7B-ii) and three (Figure 7 D-ii) signals, respectively,
suggesting that perhaps RFC40 was not knocked-down in these
RNCMs (thus behaving as an internal control). Statistical analyses
revealed significant increase in the number of aneuploid RNCMs
(monosomy and trisomy for chromosome 12) following RFC40-
siRNA treatment (Figure 7E). Furthermore, we also observed few
bi-nucleated RNCMs with unequal chromosomal distribution
(Figure 7F), similar to those observed in the hypertrophied RVs,
and nuclei that exhibited both nondisjunction for Cen12-ROX
(three signals) and micronuclei formation (Figure 7G). Moreover,
cell number analyses demonstrated that RFC40-siRNA treated
RNCMs significantly (P,0.05) decreased in cell numbers, as
compared to Untransfected (UT) RNCMs (Figure 7H). Taken
together, these data suggests that RFC40 is required for accurate
chromosomal segregation as well as cell survival/proliferation in
RNCMs.
Discussion
Adult mammalian heart is a terminally differentiated organ.
Although it is still controversial whether CMs proliferate in adult
hearts, some studies have observed no cell cycle activity and only
polyploidy in adult CMs [32], while other investigators believe that
a small fraction (1–2%) of myocytes retain their ability to replicate
throughout life [33]. However, regulation of DNA replication in
CMs is not well understood and the status of the DNA replication
machinery in adult normal and diseased CMs still remains elusive.
DNA replication in mammalian cell involves three major steps:
(i) RFC assembles into a heteropentamer and loads PCNA onto
Figure 6. Chromosomal missegregation/Aneuploidy was observed in the CM nuclei from the hypertrophied RVs. Control (Con) and
SuHxNx-5 wks (5 wks) RV sections were used to perform FISH analyses by co-hybridization of the tissues with the Cen12-ROX probe (Red). Nuclei
were counterstained with DAPI antifade (Blue) and slides were imaged with Spectral Imaging Software using an Olympus BX61 microscope with
1000X magnification. Two FISH signals for Cen12-ROX was observed in the CM nuclei from the control RV (A-i), however, one (B-i) and three (C-i)
signals were observed in the CM nuclei from the hypertrophied RVs. Localization of the CM nuclei in the control (A-ii) and hypertrophied (B–C-ii) RVs
were confirmed by performing immunohistochemical analyses for cardiac Troponin I (Green). (D) Graph represents the number of FISH signals for
Cen12-ROX observed per CM nuclei in the control and hypertrophied RVs. Fifty CM nuclei were measured from three individual animals in control and
hypertrophied RVs. (E) Diving CM nuclei undergoing chromosomal missegregation in the hypertrophied RVs, with one nucleus receiving three sister
chromatids while the other receiving only one chromatid.
doi:10.1371/journal.pone.0039009.g006
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ensures an error-free DNA synthesis and elongation prior to the
cell division. Since the status of the DNA replication proteins has
not been previously studied in the different cellular components of
the adult heart, we investigated their expression in freshly isolated
adult CMs and CFs. We found that RFC40 protein was not
expressed in either the CMs or the CFs, whereas p125 protein, the
catalytic subunit of Pol d, was expressed only in the CFs.
Furthermore, p125 mRNAs was present in both cell types.
Interestingly, however, RFC40-mRNA was detectable only in CFs
but not in CMs. These results suggest that transcription of RFC40
gene in normal adult heart is suppressed in the CMs which are
terminally differentiated, while its translation is suppressed in the
CFs. It implies that the cell regulates this vital DNA replication
protein by turning its expression off at the gene level in the
terminally differentiated cells.
Previous studies have demonstrated up-regulation of PCNA in
infarcted and failing hearts [17,18]. Similarly, cell cycle proteins
have been shown to be up-regulated in human acute myocardial
infarction and heart failure in dogs [19,20]. However, there is a
paucity of evidence demonstrating the status of core DNA
replication proteins in adult normal or diseased heart muscle,
during the pathogenesis of PAH-induced right ventricular hyper-
trophy. We, therefore, examined the expression of RFC and p125
proteins in a rat model of PAH in which pressure overload induces
both RV hypertrophy and failure [21,22]. We found that the
expression of RFC40 protein was almost completely abolished in
adult RV and LV as compared to the fetal heart, consistent with
previous observations [14]. However, we demonstrate for the first
time that RFC40 protein was re-expressed in the RVs of the
hypertrophied hearts. Furthermore, although, RFC40 and p125
mRNA levels in the control heart decreased to 10% of that in the
fetal hearts, their expression significantly increased (almost doubled
for RFC40) in the hypertrophied RV as compared to control
hearts, and that the up-regulation of these proteins occurred at the
transcriptional level in hypertrophied hearts.
Figure 7. Endogenousknock-downofRFC40inratneonatalcardiacmyocytesresultsinchromosomalmissegregation/aneuploidy.Rat
Neonatalcardiacmyocytes(RNCMs)wereisolatedasdescribedpreviouslyandgrownin12wellplatesand2-chamberedslidesfor48 hr.RNCMswerethen
treatedwithnon-targeting-siRNA(NT)andOn-TargetplussmartpoolRFC40-siRNArespectively,for72 hr.(A–DandF–G)RNCMsgrownin2-chambered
slidesweresubjectedtoFISHanalysisfollowingtreatmentwithRFC40-siRNA.Untransfected(UT)andRFC40-siRNA-RNCMslideswereco-hybridizationwith
the Cen12-ROX probe (Red). Nuclei were counterstained with DAPI antifade (Blue). RFC40 knock-down was confirmed by performing
immunohistochemicalanalysesforRFC40(A–D-iiandF–G-ii;Green)ineachsample.MergeimagesareshowninA–D-iiiandF–G-iii.PanelsA–Drepresents
RNCM nuclei aneuploidy and panels F–G represent chromosomal missegregation. White arrows point to Cen12-ROX signals. Yellow arrow points to
micronucleiinG-i&iii.(E)GraphrepresentsthenumberofsignalsforCen12-ROXobservedperRNCMnucleiintheUTandRFC40-siRNAtreatedsamples.Fifty
RNCMnucleiincontrolandRFC40-siRNAtreatedsamplesfromthreeindividualexperimentsweremeasured.(H)Beforelysingthecellsgrownin12-well
platesforwesternblotanalyses(Fig.S4),theRNCMs(n=3)weretrypsinized,resuspendedin1XPBSandcountedusingahemocytometer.Graphrepresents
the numberofRNCMsvs thedifferentRNCMtreatedsamples.Valuesaremean6SE. *indicatesP,0.05vs.Untransfected(UT).
doi:10.1371/journal.pone.0039009.g007
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replication proteins in hypertrophied hearts, we stained the
hypertrophied hearts (SUHxNX-5 wks) with RFC40 and found
RFC40 positive CMs nuclei in the hypertrophied as compared to
control RVs. Furthermore, to determine whether the CMs have
re-entered the cell cycle in the hypertrophied heart, we stained the
hypertrophied RV with a proliferative marker, PCNA, and
observed PCNA positive CMs nuclei, thereby confirming previous
observations [18]. Additionally, we also observed higher number
of cyclin A (S-phase), and phospho-Aurora kinases and phospho-
Histone 3 (G2/M-phase) positive CMs nuclei in the hypertrophied
RVs as compared to control RVs, suggesting that the CMs could
be proliferating in the PAH-induced hypertrophied RVs. Similar-
ly, several studies have demonstrated significant up-regulation in
phospho Histone 3 levels in LV hypertrophied cardiac myocytes
[34,35] and high mitotic index in various cardiac pathologies as
compared to normal hearts [36].
Toexplorethepossibilityofwhetherre-expressionofcellcycleand
core DNA replication proteins can support DNA synthesis in the
hypertrophied hearts, we performed FISH analyses on control and
SUHxNx-5 wks RVs. While we mostly observed two FISH signals
(diploid) for chromosome 12in the CM nuclei from the control RV,
the occurrence of two signals significantly decreased with frequent
occurrence of four signals (tetraploid) and concomitant doubling in
the nuclear area of the hypertrophied RV CM nuclei. These
observationsareconsistentwithpreviousfindingswhereinaincrease
in polyploidy and CM nuclear area was reported in human RV-
pressure overload [37], spontaneously hypertensive rats [38] and
myocardialinfarctinducedrathearts[39].Thesedataimpliesthatthe
CMsfromthehypertrophiedRVswereabletoundergoonecomplete
round of endoreplication through endomitosis characterized by
duplicationofthechromosomeswithoutnuclearandcellulardivision
along with the up-regulation of mitotic markers [40] suchas Aurora
kinases and H3P (Figure 4 D–E). These findings, however, are in
striking contrast to that observed in left ventricular hypertrophy,
where CMs of the hypertrophied LVs undergo several rounds of
endoreplication [19,41].
Ithasbeenshownthattetraploidcellsdemonstrateahigherdegree
of genomic instability than diploid cells and yield increased rates of
chromosomal missegregation yielding two mononuclear cells with
unequal chromosomal distribution that produce aneuploid cells in
the subsequent round of division [42]. Consistently, in addition to
diploid and tetraploid CM nuclei, we also observed significant CM
nuclei with one and three FISH signals (Figure 6 B-i and C-i),
suggesting the dominant presence of aneuploid CMs in the
hypertrophied RVs. Similar defects in chromosomal segregation
leading to aneuploidy have been reported in normal neural
progenitorcells[43];andfibroblasts[44]andbrains[45,46]derived
fromAlzheimer’sdiseasepatients.Furthermore,ithasbeenproposed
thatasinglenon-disjunctioneventcouldbetiedwithcleavagefurrow
regressionresultingintheformationofonebi-nucleatedcellwith3:1
distribution of chromosomes [47]. Consistently, we found several
dividing CM nuclei undergoing chromosomal missegregation
(similar to those observed in mononuclear cells) with one nucleus
receiving three sister chromatids while the other receiving only one
sister chromatid.
Although, we found CMs polyploidy in the hypertrophied RVs,
however, occurrence of defects in chromosomal segregation, in
these same hearts, suggest that proteins involved in chromosomal
segregation were not expressed to the fetal levels to support these
processes. In lieu with this notion, it is noteworthy to mention that
amongst all the DNA replication proteins studied in this article,
RFC40 (whose expression is suppressed in the adult heart) is the
only protein that is essential for DNA replication, DNA damage
checkpoint response [11], maintenance of genomic stability [48],
regulation of sister chromatid cohesion in mitosis and meiosis [49–
50] and accurate chromosomal segregation in Drosophila [31,49].
Consistently, immunodepletion of RFC40 from the fetal and
hypertrophied RV tissue homogenates significantly decreased the
in-vitro-DNA replication. Moreover, down-regulation of endoge-
nous RFC40 in rat neonatal (day 2) CMs resulted in chromosomal
segregation defects generating bi-nucleated RNCMs with abnor-
mal chromosomal distribution, and aneuploid RNCMs along with
micronuclei. Taken together, these data suggest that RFC40 is
required for DNA replication as well as accurate chromosomal
segregation in CMs.
Although, CM polyploidy has been previously reported in right
and left ventricular hypertrophy [18,37,41], CMs still undergo
apoptosis [51,52] during the progression of hypertrophy. Consis-
tently, a significantly increased rate of RV myocardial apoptosis
has been demonstrated in the Sugen-5416-induced PAH rat model
used in this study as compared to the control [16]. Interestingly, in
addition to defects in chromosomal segregation, we also observed
significant decrease in cell numbers, following down-regulation of
endogenous RFC40 in the neonatal CMs. This data suggests that
chromosomal missegregation/genomic instability in neonatal CMs
and absence or loss of mitotic checkpoint must be responsible for
causing cell death. We would, therefore, like to extrapolate our
observations in the neonatal rat CMs to the hypertrophied heart
rat models and speculate that chromosomal missegregation, that
we observed in the hypertrophied hearts, may be responsible for
causing CM death during the progression of hypertrophy. A
fascinating comparison can be drawn from the adult neurons
which are also known to be post-mitotic like the CMs [53]. It has
been shown that neurons derived from Alzheimer’s disease
patients re-enter cell cycle and undergo DNA replication.
However, the frequency of tetraploid and aneuploid neurons are
high in these patients [45,46], predisposing them to cell death or
apoptotic clearance [46,53,54]. Nonetheless, absence or down-
regulation of other unknown factors influencing DNA replication,
chromosomal segregation and cell cycle regulation in the adult
CMs cannot be ruled out and warrants further investigation.
In conclusion, our novel findings suggest that transcription of
RFC40 gene and translation of p125 protein is suppressed in the
adult CMs. Furthermore, marginal re-expression (as compared to
fetal hearts) of RFC40 protein, which is required for both DNA
replication and chromosomal segregation, is not sufficient to
support accurate chromosomal segregation in PAH-induced right
ventricular hypertrophied CMS. Finally, absence of RFC40
protein in the adult heart due to transcriptional suppression
provides potential explanation for the stalling of DNA replication
in the adult heart.
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